1.A study on the trend in the length of hospital stay in Korea.
Woo Hyun CHO ; Ki Hong CHUNG ; Im Ok KANG
Korean Journal of Preventive Medicine 1996;29(1):51-66
The purpose of this study was to examine the trends of length of hospital stay (LOS), which is most likely to be a major attribute to hospital performance From 1984 to 1994, an average LOS of each hospital was analyzed by factors such as medical departments, bed size, occupancy rate, region and ownership. This study was analyzed changing rate of LOS during 11 years. This rate was calculated by simple regression, which was used only with hospital without missing data during 11 years. This study findings are as follows. 1. The results indicated that the average LOS was steadily increased until 1990 but it was slightly decreased after 1990. 2. This trend could be found in all hospital scale and all group of occupancy rate. Specifically this trends of LOS were found in internal medicine, corporate owned hospitals, and hospitals in major city. But LOS of individual owned hospital was continuously increased until 1994. 3. Means of changing rates of LOS were calculated from 1984 to 1994. If we divided it into two parts, before 1990 and after 1990, most changing rates of LOS before 1990 except individual owned hospital were found positive sign. The changing rates after 1990 were negative sign but small hospital(lesser then 200 bed), individual owned hospital, national & public hospital and hospital in small urban have little change of LOS after 1990. Finally from this results we thought that most hospitals in korea began to be concerned with LOS. Nevertheless LOS of several hospital such as small hospital or individual owned hospital was increased. And this trend may be caused by a few patients, low occupancy rate, or low profit. This trend of LOS is different from that of other countries. Perhaps this phenomenon is resulted from the reimbursement method. Because of fee for service reimbursement system in korea the hospitals didn't need to shorten LOS in order to save the cost and increase the profit. Therefore reform of hospital cost reimbursement method will be reduced to reduce hospital cost in korea. we thought that the korean health authority should consider the reimbursement method by unit of bundle of services, for example DRG and prepayment in the united states. This study presents some limitations such as on insight of severity of disease, case-mix measurement of hospital, and other clinical characteristics that can possibly affect LOS, However, this study reports an important trend in LOS from 1984 to 1994.
Diagnosis-Related Groups
;
Fee-for-Service Plans
;
Hospital Bed Capacity
;
Hospital Costs
;
Hospitals, Public
;
Humans
;
Internal Medicine
;
Korea*
;
Length of Stay*
;
Ownership
;
United States
2.A Case of Hyperthyroidism.
Cheol Woon BEAK ; Seung Geun HONG ; Sang Geel LEE ; Im Joo KANG
Journal of the Korean Pediatric Society 1983;26(10):1033-1038
No abstract available.
Hyperthyroidism*
3.Electron Microscopic Study of the Renal Proximal and Distal Convuluted Tubular Epithelial and Distal Convoluted Tubular Epithelial Cells after Administration of Aspirin.
Sung Gum HONG ; Cheul Woon BACK ; Im Ju KANG ; Byung Heon KIM ; Dong Koo LEE
Journal of the Korean Pediatric Society 1983;26(6):564-572
No abstract available.
Aspirin*
;
Epithelial Cells*
4.A Case of pulmonary lymphangioleiomyomatosis developed in tuberous sclerosis with renal angiomyolipoma.
Myung Im KIM ; Hong Mo KANG ; Ho Jong LEE ; Yong Ho KOH ; Yong Seon CHO ; Jee Hong YOO
Tuberculosis and Respiratory Diseases 2000;48(5):788-793
Tuberous sclerosis is a rare hereditary anomaly of variable penetrance characterized by mental retardation, epilepsy, and adenoma sebaceum. Pulmonary involvement is uncommon, but, when involve by tuberous sclerosis, it shows characteristic reticulonodular infiltration and cystic changes. Lymphangioleiomyomatosis is a rare disease of unknown cause that affects women of reproductive age. It is characterized by progressive proliferation of smooth muscle in the lung. We experienced one case of pulmonary lymphangioleiomyomatosis associated with tuberous sclerosis in a 26-year-old female patient. This case is reported with a brief of the literature.
Adult
;
Angiomyolipoma*
;
Epilepsy
;
Female
;
Humans
;
Intellectual Disability
;
Lung
;
Lymphangioleiomyomatosis*
;
Muscle, Smooth
;
Penetrance
;
Rare Diseases
;
Tuberous Sclerosis*
5.Primary Pulmonary Hodgkin's Lymphoma: A case report.
Mi Seon KWON ; Kyo Young LEE ; Chang Suk KANG ; Byung Kee KIM ; Sang In SHIM ; Myeong Im AHN ; Chi Hong KIM
Korean Journal of Pathology 1999;33(4):285-287
Primary pulmonary Hodgkin's lymphoma is a rare but distinct entity to be distinguished from nodal Hodgkin's lymphoma and from lymphomas involving lung secondarily. This lymphoma affects women more frequently than men, and typically involves superior portions of the lung. This case is reported to illustrate the clinical, radiographic and anatomic characteristics of the primary pulmonary Hodgkin's lymphoma. A 34-year-old woman presented for the evaluation of hemoptysis. A chest CT revealed a large poorly defined mass in the medial aspect of the right upper lobe, extending to the right mediastinum and trachea. The microscopic examination of the biopsied lesion revealed fibroblastic stroma infiltrated by a mixture of lymphocytes, histiocytes, and eosinophils. The clinical impression was inflammatory pseudotumor, presumably due to slightly favorable response to corticosteroid therapy. Two months later the patient's symptoms worsened despite the steroid therapy and a lobectomy was done. The specimen showed a soft to firm, pale yellow, ill defined mass, 10.0 8.0 cm, involving the visceral pleura. A few satellite nodules around the main mass were noted. The histologic findings were consistent with Hodgkin's lymphoma, nodular sclerosis type.
Adult
;
Eosinophils
;
Female
;
Fibroblasts
;
Granuloma, Plasma Cell
;
Hemoptysis
;
Histiocytes
;
Hodgkin Disease*
;
Humans
;
Lung
;
Lymphocytes
;
Lymphoma
;
Male
;
Mediastinum
;
Pleura
;
Sclerosis
;
Tomography, X-Ray Computed
;
Trachea
6.A study on appropriateness of price of medical care service in health insurance.
Ki Hong CHUN ; Kui Son CHOI ; Im Ok KANG
Korean Journal of Preventive Medicine 1998;31(3):460-470
By expanding health insurance, customers will carry a smaller burden of medical costs. As a result, the number of visits to a physician increase and this result in the improvement of medical accessibility. But medical care utilization may be changed not only by insurance status but also by socio-demographic factor, economic status and other factors. The question thus remains, at which level of accessibility and what price of medical care service in health insurance will the customer and the medical care service be satisfied. The price of medical care service is comprised of the customer's out-of-pocket money and the costs not covered by health insurance. If the price of medical care services in health insurance are appropriate, medical care utilization should not differ because of the difference in income status or the acuteness of illness. But If the price is not adequate, low income groups will receive relatively low medical care utilization, particularly in the case of chronic disease. The purpose of this study is to evaluate the differences in medical care utilization among the various income groups and those with varying acuteness of illness. The major hypotheses to test in this study are : (I) whether there are differences in medical care utilization among different income groups exist, (II) whether differences in medical care utilization among different income groups exist with the hospital type. (III) whether differences in medical care utilization among different income groups exist with the acuteness of illness and with age. The data was collected from the JongRo District Health Insurance Society in Seoul. A total of 118,336 persons were selected as the final sample for this study. The major findings of this study were as follows ; 1. The volume of ambulatory utilization among users was statistically significant by income level. 2. Among different income groups, the volume of ambulatory utilization was statistically significant by the acuteness of illness. 3. Higher income groups with chronic diseases had a greater volume of ambulatory utilization than other groups.
Chronic Disease
;
Humans
;
Insurance Coverage
;
Insurance, Health*
;
Seoul
7.Species Differences in Effect of Ethanol to Urinary Metabolites Excretion of Trichloroethylene in Mice and Rats.
Eun Yong KANG ; Jung Duck PARK ; Yeon Pye HONG ; Im Won CHANG
Korean Journal of Preventive Medicine 1998;31(4):680-691
This study was conducted to examine the species differences in the urinary excretion of trichloroethanol(TCE-OH) and trichloroacetic acid(TCA) of trichloroethylene(TCE) metabolites and the effect of ethanol on these metabolites in mice and rats. TCE administered to Male Sprague Dawley rats and ICR mice as a single oral dose(100, 200, 500, 1,000 or 2,000 mg/kg body weight) and ethanol(3.0 g/kg body weight) was taken orally 12 hours before TCE administration. The metabolites in urine were measured 0, 12, 24, 36 and 48 hours after TCE administration. The results of metabolite excretion were as follows; Total trichlorocompounds(TTC) in urine increased with TCE dose in mice while increased only below dose of 1,000 mg/kg TCE in rats. The net excretion of TCE metabolites was significantly greater in mice than rats, although the proportion of TCE-OH to TCA was not different between mice and rats. These findings indicate that mice were internally exposed to significantly higher concentration of TCE metabolites than rats and this trend appeared to be more prominent with the increase of TCE dose. Ethanol increased significantly TCE-OH in urine of rats while the increase of TCE-OH induced by ethanol was not significant in mice, and didn't increase TCA of urine in both of rats and mice. This result suggests that the effect of ethanol on TCE metabolism may be due to the increase of TCE-OH.
Animals
;
Ethanol*
;
Humans
;
Male
;
Metabolism
;
Mice*
;
Mice, Inbred ICR
;
Rats*
;
Rats, Sprague-Dawley
;
Trichloroethylene*
8.The Comparisons of Clincal Results of Ac rySof and PMMA Intraocular Lens Implantation in Diabetic Cataract: Six Months Follow-up.
Kang Seok LEE ; Im Tae KIM ; Jong Wook HONG
Journal of the Korean Ophthalmological Society 1999;40(8):2160-2166
To compare the clinical results of AcrySof intraocular lens (IOL)and Polymethyl methacrylate(PMMA)IOL implantation in diabetic patients,a total of 58 eyes(48 patients)were analyzed.AcrySof IOL was implanted in 24 eyes with small incision technique,and PMMA IOL was implanted in 34 eyes with enlarged scleral wound.Posterior capsular opacity(PCO)developed in only 2 eyes in AcrySof group,while it occurred in 4 eyes in PMMA group.Anterior capsular fibrosis developed in 4 eyes and IOL-iris synechiae developed in 2 eyes in PMMA group after follow-up of 6 months.No statis-tically significant difference was found in the incidence of PCO between two groups(p>0.05). AcrySof IOL leads to faster visual rehabilitation than PMMA lens. Therefore,use of AcrySof IOL can be more beneficial in diabetic cataractpatients who might need laser photocoagulation or pars plana vitrectomy in the future.
Cataract*
;
Fibrosis
;
Follow-Up Studies*
;
Incidence
;
Lens Implantation, Intraocular*
;
Lenses, Intraocular*
;
Light Coagulation
;
Polymethyl Methacrylate*
;
Rehabilitation
;
Vitrectomy
9.Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer.
Mijeong IM ; Jin Kyung LEE ; Young Joon HONG ; Seok Il HONG ; Hye Jin KANG ; Im Il NA ; Baek Yeol RYOO ; Gi Jeong CHEON ; Ha Na LEE ; Yoon Hwan CHANG
The Korean Journal of Laboratory Medicine 2008;28(6):425-429
Ionizing radiation including I131 might produce chromosomal translocation, causing hematologic malignancy. The incidence of leukemia following radioactive iodine treatment for thyroid cancer has been reported to be approximately 0.1 to 2.0% in Western countries, whereas fewer cases have been reported in Korea. We hereby report four cases of secondary hematologic malignancy, who received iodine therapy for thyroid cancer after thyroidectomy: two cases of acute lymphoblastic leukemia with t(9;22)(q34;q11.2), a case of MDS with 5q deletion, and a case of MDS with normal karyotype. Three cases of hematologic malignancy have developed after cumulative dosage of less than 800 mCi. The treatment intervals in two cases were less than 12 months, and the other two cases had I131 therapy only once. Assessment of causality using the Naranjo probability scale for adverse drug reactions showed that a 'possible' relationship existed between the use of I131 and secondary hematologic malignancy in all of the four cases in this report.
Adult
;
Chromosomes, Human, Pair 22
;
Chromosomes, Human, Pair 5
;
Chromosomes, Human, Pair 9
;
Female
;
Gene Deletion
;
Hematologic Neoplasms/*diagnosis/genetics
;
Humans
;
Iodine Radioisotopes/*adverse effects/therapeutic use
;
Leukemia, Radiation-Induced/*diagnosis/etiology
;
Middle Aged
;
Myelodysplastic Syndromes/diagnosis/genetics
;
Neoplasms, Second Primary/*diagnosis/genetics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics
;
Thyroid Neoplasms/*radiotherapy
;
Thyroidectomy
;
Translocation, Genetic
10.A Case of Neurilemmoma of the Chest Wall.
Yong Ho KOH ; Myoung Im KIM ; Min Soo HAN ; Jee Hong YOO ; Hong Mo KANG
Tuberculosis and Respiratory Diseases 1999;46(4):580-585
Neurilemmoma is a benign nerve sheath tumor derived from Schwann cells and occurs in the head, neck, flexor regions of the extremities, posterior mediastinum but extremely rare in the chest wall. They occur at all ages but are most common in persons between the ages of 20 and 50 years and develop spontaneously or possible as a result of trauma or irritation. The diagnosis of a neurilemmoma is confirmed histologically by the findings of Verocay bodies, Antoni A and B tissue patterns and the presence of S-100 protein. We experienced a case of chest wall neurilemmoma which was treated by local excision and report it with a brief review of the literature.
Diagnosis
;
Extremities
;
Head
;
Humans
;
Mediastinum
;
Neck
;
Neurilemmoma*
;
S100 Proteins
;
Schwann Cells
;
Thoracic Wall*
;
Thorax*